Grossman HB - Search Results

1

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients.

Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, Wu X. Chen M, et al. Among authors: grossman hb. Carcinogenesis. 2010 Aug;31(8):1387-91. doi: 10.1093/carcin/bgq110. Epub 2010 Jun 7. Carcinogenesis. 2010. PMID: 20530239 Free PMC article.

2

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X. Gu J, et al. Among authors: grossman hb. Clin Cancer Res. 2005 Feb 15;11(4):1408-15. doi: 10.1158/1078-0432.CCR-04-1101. Clin Cancer Res. 2005. PMID: 15746040

3

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study.

Gu J, Spitz MR, Zhao H, Lin J, Grossman HB, Dinney CP, Wu X. Gu J, et al. Among authors: grossman hb. Carcinogenesis. 2005 Oct;26(10):1741-7. doi: 10.1093/carcin/bgi126. Epub 2005 May 19. Carcinogenesis. 2005. PMID: 15905204

4

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.

Leibovici D, Grossman HB, Dinney CP, Millikan RE, Lerner S, Wang Y, Gu J, Dong Q, Wu X. Leibovici D, et al. Among authors: grossman hb. J Clin Oncol. 2005 Aug 20;23(24):5746-56. doi: 10.1200/JCO.2005.01.598. J Clin Oncol. 2005. PMID: 16110031

5

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.

Gu J, Grossman HB, Dinney CP, Wu X. Gu J, et al. Among authors: grossman hb. Pharmacogenomics. 2005 Sep;6(6):575-84. doi: 10.2217/14622416.6.6.575. Pharmacogenomics. 2005. PMID: 16142998 Review.

6

Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.

Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X. Zhu Y, et al. Among authors: grossman hb. Carcinogenesis. 2007 Mar;28(3):698-703. doi: 10.1093/carcin/bgl201. Epub 2006 Oct 19. Carcinogenesis. 2007. PMID: 17052994

7

Genetic polymorphism in bladder cancer.

Wu X, Lin X, Dinney CP, Gu J, Grossman HB. Wu X, et al. Among authors: grossman hb. Front Biosci. 2007 Jan 1;12:192-213. doi: 10.2741/2058. Front Biosci. 2007. PMID: 17127293 Review.

8

Matrix metalloproteinase polymorphisms and bladder cancer risk.

Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X. Kader AK, et al. Among authors: grossman hb. Cancer Res. 2006 Dec 15;66(24):11644-8. doi: 10.1158/0008-5472.CAN-06-1212. Cancer Res. 2006. PMID: 17178858

9

High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.

Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. Huang M, et al. Among authors: grossman hb. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91. doi: 10.1158/1055-9965.EPI-06-0712. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220334

10

Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.

Kader AK, Liu J, Shao L, Dinney CP, Lin J, Wang Y, Gu J, Grossman HB, Wu X. Kader AK, et al. Among authors: grossman hb. Clin Cancer Res. 2007 May 1;13(9):2614-20. doi: 10.1158/1078-0432.CCR-06-1187. Clin Cancer Res. 2007. PMID: 17473191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page